Irritable bowel syndrome in adolescents in Lagos

Oluwafunmilayo Funke Adeniyi1, Olufunmilayo Adenike Lesi2, Foluke Adenike Olatona3

  • 1Department of Paediatrics, College of Medicine, University of Lagos,Lagos University Teaching Hospital, Idi-Araba, Lagos, Nigeria.

Insights

Irritable bowel syndrome (IBS) affects 16% of Nigerian children, being more common in females. Early diagnosis is crucial for managing recurrent abdominal pain in pediatric patients.

Area of Science:

  • Pediatric Gastroenterology
  • Epidemiology
  • Functional Gastrointestinal Disorders

Background:

  • Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder (FGID) often presenting as recurrent abdominal pain.
  • While well-described in Western populations, data on IBS prevalence in African children is limited.

Purpose of the Study:

  • To determine the prevalence of IBS among children in Western Nigeria.
  • To raise physician awareness regarding IBS in pediatric patients with abdominal pain.

Main Methods:

  • A cross-sectional study involving 8 schools in Lagos State, Nigeria.
  • Utilized the Rome III criteria for IBS assessment in children aged 10-18 years.
  • Employed multistage stratified random sampling to identify risk factors and symptoms.

Main Results:

  • The prevalence of IBS was 16.0% in the study population.
  • IBS was more prevalent in females (p=0.000) and decreased with increasing age (p=0.05).
  • Significant risk factors included female gender, socioeconomic status, and prior gastroenteritis.

Conclusions:

  • IBS is a prevalent condition in African children.
  • Healthcare providers should maintain a high index of suspicion for IBS in children with unexplained abdominal pain.
  • Further longitudinal research in African pediatric populations is recommended.
Abstract

Related Concept Videos

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
957
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
917
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
1.2K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
817
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
754
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
915